{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:13:23Z","timestamp":1752228803734},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"no"},{"name":"MalarvxInc."},{"name":"Malarvx Inc.","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Plasmodium falciparum<\/jats:italic>zygotes develop in the mosquito midgut after an infectious blood meal containing mature male and female gametocytes. Studies of mosquito-produced<jats:italic>P. falciparum<\/jats:italic>zygotes to elucidate their biology and development have been hampered by high levels of contaminating mosquito proteins and macromolecules present in zygote preparations. Thus, no zygote-specific surface markers have been identified to date. Here, a methodology is developed to obtain large quantities of highly purified zygotes using in vitro culture, including purification methods that include magnetic column cell separation (MACS) followed by Percoll density gradient centrifugation. This straightforward and effective approach provides ample material for studies to enhance understanding of zygote biology and identify novel zygote surface marker candidates that can be tested as transmission blocking vaccine (TBV) candidates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:italic>Plasmodium falciparum<\/jats:italic>gametocyte cultures were established and maintained from asexual cultures. Gametocytes were matured for 14\u00a0days, then transferred into zygote media for 6 h at 27\u2009\u00b1\u20092\u00a0\u00b0C to promote gamete formation and fertilization. Zygotes were then purified using a combination of MACS column separation and Percoll density gradient centrifugation. Purity of the zygotes was determined through morphological studies: the parasite body and nuclear diameter were measured, and zygotes were further transformed into ookinetes. Immunofluorescence assays (IFA) were also performed using the ookinete surface marker, Pfs28.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After stimulation, the culture consisted of transformed zygotes and a large number of uninfected red blood cells (RBCs), as well as infected RBCs with parasites at earlier developmental stages, including gametes, gametocytes, and asexual stages. The use of two MACS columns removed the vast majority of the RBCs and gametocytes. Subsequent use of two Percoll density gradients enabled isolation of a pure population of zygotes. These zygotes transformed into viable ookinetes that expressed Pfs28.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The combined approach of using two MACS columns and two Percoll density gradients yielded zygotes with very high purity (45-fold enrichment and a pure population of zygotes [approximately 100%]) that was devoid of contamination by other parasite stages and uninfected RBCs. These enriched zygotes, free from earlier parasites stages and mosquito-derived macromolecules, can be used to further elucidate the biology and developmental processes of<jats:italic>Plasmodium.<\/jats:italic><\/jats:p><\/jats:sec>","DOI":"10.1186\/s12936-020-03237-1","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T14:02:58Z","timestamp":1590415378000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Purification and production of Plasmodium falciparum zygotes from in vitro culture using magnetic column and Percoll density gradient"],"prefix":"10.1186","volume":"19","author":[{"given":"Yaxian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis M.","family":"Grieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie S.","family":"Itsara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley M.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil K.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,25]]},"reference":[{"key":"3237_CR1","unstructured":"WHO. World Malaria Report 2017. Geneva: World Health Organization; 2017. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259492\/9789241565523-eng.pdf;jsessionid=FDAF504C4F395E17BFB878B303B0D2B8?sequence=12017:90. Accessed 20 Oct 2017."},{"key":"3237_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1473-3099(04)01043-6","volume":"4","author":"SI Hay","year":"2004","unstructured":"Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis. 2004;4:327\u201336.","journal-title":"Lancet Infect Dis"},{"key":"3237_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0169-4758(99)01626-9","volume":"16","author":"A Ghosh","year":"2000","unstructured":"Ghosh A, Edwards MJ, Jacobs-Lorena M. The journey of the malaria parasite in the mosquito: hopes for the new century. Parasitol Today. 2000;16:196\u2013201.","journal-title":"Parasitol Today"},{"key":"3237_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0092-8674(01)00199-4","volume":"104","author":"MR van Dijk","year":"2001","unstructured":"van Dijk MR, Janse CJ, Thompson J, Waters AP, Braks JA, Dodemont HJ, et al. A central role for P48\/45 in malaria parasite male gamete fertility. Cell. 2001;104:153\u201364.","journal-title":"Cell"},{"key":"3237_CR5","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.4049\/jimmunol.139.12.4213","volume":"139","author":"IA Quakyi","year":"1987","unstructured":"Quakyi IA, Carter R, Rener J, Kumar N, Good MF, Miller LH. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. J Immunol. 1987;139:4213\u20137.","journal-title":"J Immunol"},{"key":"3237_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0014-4894(90)90025-8","volume":"71","author":"HC Fries","year":"1990","unstructured":"Fries HC, Lamers MB, van Deursen J, Ponnudurai T, Meuwissen JH. Biosynthesis of the 25-kDa protein in the macrogametes\/zygotes of Plasmodium falciparum. Exp Parasitol. 1990;71:229\u201335.","journal-title":"Exp Parasitol."},{"key":"3237_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1128\/IAI.65.3.1109-1113.1997","volume":"65","author":"PE Duffy","year":"1997","unstructured":"Duffy PE, Kaslow DC. A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines. Infect Immun. 1997;65:1109\u201313.","journal-title":"Infect Immun"},{"key":"3237_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-3024.1990.tb00990.x","volume":"12","author":"R Carter","year":"1990","unstructured":"Carter R, Graves PM, Keister DB, Quakyi IA. Properties of epitopes of Pfs 48\/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of Plasmodium falciparum. Parasite Immunol. 1990;12:587\u2013603.","journal-title":"Parasite Immunol"},{"issue":"Suppl 2","key":"3237_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1590\/S0074-02761994000600004","volume":"89","author":"W Roeffen","year":"1994","unstructured":"Roeffen W, Lensen T, Mulder B, Teelen K, Sauerwein R, Eling W, et al. Transmission blocking immunity as observed in a feeder system and serological reactivity to Pfs 48\/45 and Pfs230 in field sera. Mem Inst Oswaldo Cruz. 1994;89(Suppl 2):13\u20135.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"3237_CR10","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1128\/EC.00060-07","volume":"8","author":"AK Saxena","year":"2007","unstructured":"Saxena AK, Wu Y, Garboczi DN. Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines. Eukaryot Cell. 2007;8:1260\u20135.","journal-title":"Eukaryot Cell"},{"key":"3237_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/0035-9203(83)90280-8","volume":"77","author":"AN Vermeulen","year":"1983","unstructured":"Vermeulen AN, Ponnudurai T, Lensen AH, Roeffen WF, Meuwissen JE. The purification of Plasmodium falciparum macrogametes and\/or zygotes prepared from in vitro cultures. Trans R Soc Trop Med Hyg. 1983;77:753\u20135.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3237_CR12","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1084\/jem.162.5.1460","volume":"1","author":"AN Vermeulen","year":"1985","unstructured":"Vermeulen AN, Ponnudurai T, Beckers PI, Verhave JP, Smits MA, Meuwissen JH. Sequential expression of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J Exp Med. 1985;1:1460\u201376.","journal-title":"J Exp Med"},{"key":"3237_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0166-6851(83)90034-8","volume":"8","author":"DC Kaushal","year":"1983","unstructured":"Kaushal DC, Carter R, Howard RJ, McAuliffe FM. Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. I. Zygote surface antigens. Mol Biochem Parasitol. 1983;8:53\u201369.","journal-title":"Mol Biochem Parasitol"},{"key":"3237_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.molbiopara.2012.10.004","volume":"186","author":"AM Vaughan","year":"2012","unstructured":"Vaughan AM, Mikolajczak SA, Camargo N, Lakshmanan V, Kennedy M, Lindner SE, et al. A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle. Mol Biochem Parasitol. 2012;186:143\u20137.","journal-title":"Mol Biochem Parasitol"},{"key":"3237_CR15","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1172\/JCI62684","volume":"122","author":"AM Vaughan","year":"2012","unstructured":"Vaughan AM, Mikolajczak SA, Wilson EM, Grompe M, Kaushansky A, Camargo N, et al. Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest. 2012;122:3618\u201328.","journal-title":"J Clin Invest"},{"key":"3237_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/1475-2875-9-194","volume":"9","author":"AK Ghosh","year":"2010","unstructured":"Ghosh AK, Dinglasan RR, Ikadai H, Jacobs-Lorena M. An improved method for the in vitro differentiation of Plasmodium falciparum gametocytes into ookinetes. Malar J. 2010;9:194.","journal-title":"Malar J"},{"key":"3237_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-62703-026-7_3","volume":"923","author":"AK Ghosh","year":"2013","unstructured":"Ghosh AK, Jacobs-Lorena M. In vitro differentiation of Plasmodium falciparum gametocytes into ookinetes. Methods Mol Biol. 2013;923:27\u201333.","journal-title":"Methods Mol Biol"},{"key":"3237_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12936-018-2277-6","volume":"17","author":"LS Itsara","year":"2018","unstructured":"Itsara LS, Zhou Y, Do J, Dungel S, Fishbaugher ME, Betz WW, et al. PfCap380 as a marker for Plasmodium falciparum oocyst development in vivo and in vitro. Malar J. 2018;17:135.","journal-title":"Malar J"},{"key":"3237_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1475-2875-2-35","volume":"2","author":"V Carter","year":"2003","unstructured":"Carter V, Cable HC, Underhill BA, Williams J, Hurd H. Isolation of Plasmodium berghei ookinetes in culture using Nycodenz density gradient columns and magnetic isolation. Malar J. 2003;2:35.","journal-title":"Malar J"},{"key":"3237_CR20","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.4269\/ajtmh.2010.10-0433","volume":"83","author":"V Bounkeua","year":"2010","unstructured":"Bounkeua V, Li F, Vinetz JM. In vitro generation of Plasmodium falciparum ookinetes. Am J Trop Med Hyg. 2010;83:1187\u201394.","journal-title":"Am J Trop Med Hyg"},{"key":"3237_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fcimb.2017.00320","volume":"7","author":"CJ Ngwa","year":"2017","unstructured":"Ngwa CJ, Kiesow MJ, Papst O, Orchard LM, Filarsky M, Rosinski AN, et al. Transcriptional profiling defines histone acetylation as a regulator of gene expression during human-to-mosquito transmission of the malaria parasite Plasmodium falciparum. Front Cell Infect Microbiol. 2017;7:320\u201339.","journal-title":"Front Cell Infect Microbiol"},{"key":"3237_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0169-4758(91)90127-A","volume":"7","author":"A Warburg","year":"1991","unstructured":"Warburg A, Miller LH. Critical stages in the development of Plasmodium in mosquitoes. Parasitol Today. 1991;7:179\u201381.","journal-title":"Parasitol Today"},{"key":"3237_CR23","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1093\/emboj\/18.22.6221","volume":"18","author":"JT Dessens","year":"1999","unstructured":"Dessens JT, Beetsma AL, Dimopoulos G, Wengelnik K, Crisanti A, Kafatos FC, et al. CTRP is essential for mosquito infection by malaria ookinetes. EMBO J. 1999;18:6221\u20137.","journal-title":"EMBO J"},{"key":"3237_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1022513327982","volume":"19","author":"Y Marikovsky","year":"2002","unstructured":"Marikovsky Y, Marikovsky M. Clearance of senescent erythrocytes: wheat germ agglutinin distribution on young and old human erythrocytes. Glycoconj J. 2002;19:1\u20134.","journal-title":"Glycoconj J"},{"key":"3237_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1475-2875-10-96","volume":"10","author":"C Spadafora","year":"2011","unstructured":"Spadafora C, Gerena L, Kopydlowski KM. Comparison of the in vitro invasive capabilities of Plasmodium falciparum schizonts isolated by Percoll gradient or using magnetic based separation. Malar J. 2011;10:96.","journal-title":"Malar J"},{"key":"3237_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1475-2875-7-45","volume":"7","author":"C Ribaut","year":"2008","unstructured":"Ribaut C, Berry A, Chevalley S, Reybier K, Morlais I, Parzy D, et al. Concentration and purification by magnetic separation of the erythrocytic stages of all human Plasmodium species. Malar J. 2008;7:45.","journal-title":"Malar J"},{"key":"3237_CR27","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1128\/IAI.45.3.775-777.1984","volume":"45","author":"CA Grotendorst","year":"1984","unstructured":"Grotendorst CA, Kumar N, Carter R, Kaushal DC. A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies. Infect Immun. 1984;45:775\u20137.","journal-title":"Infect Immun"},{"key":"3237_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1128\/IAI.59.1.36-44.1991","volume":"59","author":"N Tirawanchai","year":"1991","unstructured":"Tirawanchai N, Winger LA, Nicholas J, Sinden RE. Analysis of immunity induced by the affinity-purified 21-kilodalton zygote-ookinete surface antigen of Plasmodium berghei. Infect Immun. 1991;59:36\u201344.","journal-title":"Infect Immun"},{"key":"3237_CR29","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1128\/IAI.65.6.2260-2264.1997","volume":"65","author":"T Tsuboi","year":"1997","unstructured":"Tsuboi T, Cao YM, Hitsumoto Y, Yanagi T, Kanbara H, Torii M. Two antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunity. Infect Immun. 1997;65:2260\u20134.","journal-title":"Infect Immun"},{"key":"3237_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1128\/IAI.70.1.102-106.2002","volume":"70","author":"RC Langer","year":"2002","unstructured":"Langer RC, Li F, Vinetz JM. Identification of novel Plasmodium gallinaceum zygote- and ookinete-expressed proteins as targets for blocking malaria transmission. Infect Immun. 2002;70:102\u20136.","journal-title":"Infect Immun"},{"key":"3237_CR31","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.3389\/fimmu.2018.02748","volume":"9","author":"LS Itsara","year":"2018","unstructured":"Itsara LS, Zhou Y, Do J, Grieser AM, Vaughan AM, Ghosh AK. The development of whole sporozoite vaccines for Plasmodium falciparum malaria. Front Immunol. 2018;9:2748.","journal-title":"Front Immunol"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03237-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-020-03237-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03237-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T12:48:21Z","timestamp":1696164501000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-03237-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,25]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3237"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-03237-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,25]]},"assertion":[{"value":"23 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Several authors, as indicated, are employed by a malaria vaccine company, MalarVx, Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}